3-Oxoisoindoline-5-carboxylic acid, 95.0%, 100mg

5-HEPTENOIC ACID, 7-[(1R,2R,3R,5S)-3,5-DIHYDROXY-2-[(1E,3R)-3-HYDROXY-4-[3-(TRIFLUOROMETHYL)PHENOXY]-1-BUTEN-1-YL]CYCLOPENTYL]-, 1-METHYLETHYL ESTER, (5Z)-, 98%, 1g

2-Amino-6-isopropyl-4-pyrimidinol, 95.0%, 1g

5-Bromo-3-iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 97%, 1g

Diethyl 2-oxooctane-1,8-dicarboxylate, 97.0%, 1g

3-Chloroaniline, >=98%, for synthesis, 250mL, glass packaging

(S)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-amino-5-oxopentanoic acid, 95.0%, 5g

3,4-Pyridinecarboximide, 95.0%, 1g

6-Nitropyridine-2-carboxylic acid, 95.0%, 5g

1-((4-(2-Methoxyphenoxy)phenyl)sulfonamido)cyclohexane-1-carboxylic acid, 97%, 100mg

2-Bromothiophene, 98.0%, 50g

2-(3-(Dimethylamino)propoxy)-5-(trifluoromethyl)aniline, 95.0%, 250mg

Methyl 3-amino-4-fluorobenzoate, 95.0%, 5g